Indo US Bio-Tech Ltd.
Listed
BSE SME
SME
Live Chart
| Category | Subscription | Shares Offered | % of Total | Amount (₹Cr) |
|---|---|---|---|---|
|
Market Maker
|
Awaited |
74,000
5.17% |
5.17%
|
₹0.38 |
|
QIB
|
Over 1.00x
|
— | — | — |
|
NII / HNI
|
Over 1.00x
|
678,000
47.41% |
47.41%
|
₹3.46 |
|
Retail
|
Over 1.00x
|
678,000
47.41% |
47.41%
|
₹3.46 |
| Total | 1.00x | 1,430,000 |
100% | ₹7.29 |
| Category | Shares Offered | Amount (₹Cr) | Size (%) |
|---|---|---|---|
| Market Maker | 74,000 | ₹0.38 |
5.17%
|
| NII | 678,000 | ₹3.46 |
47.41%
|
| Retail | 678,000 | ₹3.46 |
47.41%
|
| Total | 1,430,000 | ₹7.29 |
100.00%
|
| QIB | NII | Retail | Total | |||||
|---|---|---|---|---|---|---|---|---|
| Ex. Anchor | Anchor | Total QIB | Below ₹10L | Above ₹10L | Total NII | |||
| Allocation (shares) | — | — | — | — | — | 678,000 | 678,000 | 1,356,000 |
| Allotment price (₹) | 51 | 51 | 51 | 51 | 51 | 51 | 51 | 51 |
| No. of applications | — | — | — | — | — | — | — | — |
| No. of shares applied | — | — | — | — | — | — | — | — |
| Amount collected (₹Cr) | — | — | — | — | — | — | ₹3.46 | ₹3.46 |
| Times subscribed | 1 | — | — | — | — | 1 | 1 | 1 |
| Shares allotted | — | — | — | — | — | 678,000 | 678,000 | 1,356,000 |
| No. of allottees | — | — | — | — | — | — | — | — |
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min — 2 Lots) | 2 | 4,000 | ₹204,000 |
| Retail (Max — 13 Lots) | 13 | 26,000 | ₹1,326,000 |
| S-HNI (Min — 14 Lots) | 14 | 28,000 | ₹1,428,000 |
| B-HNI (Min — 68 Lots) | 68 | 136,000 | ₹6,936,000 |
Indo US Bio-Tech Ltd. is proposing an IPO on BSE SME under the SME category. Total issue: 14,30,000 shares (aggregating up to ₹7.29 Cr).
Opens 30 Apr 2018, closes 03 May 2018. Listing: 11 May 2018. Apply via ASBA or UPI.
| Particulars | 31-Mar-17 | 31-Mar-16 | 31-Mar-15 |
|---|---|---|---|
| Revenue from Operations | 2457.79 | 1914.53 | 1966.07 |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | 64.99 | 35.99 | 49.59 |
| Net Worth | N/A | N/A | N/A |
| Total Assets | 1293.66 | 1368.76 | 767.52 |
| Reserves & Surplus | N/A | N/A | N/A |
| Borrowings | N/A | N/A | N/A |
| EBITDA Margin (%) | N/A | — | — |
| PAT Margin (%) | N/A | — | — |
Indo US Bio-Tech Ltd. IPO is subscribed 1.00 times by May 03, 2018. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.
| Investor Category | Subscription |
|---|---|
| Qualified Institutional (QIB) | 1.00x |
| Non Institutional (NII/HNI) | 1.00x |
| Retail Individual | 1.00x |
| Total Subscription | 1.00x |
The Indo US Bio-Tech Ltd. IPO retail category is subscribed 1.00 times as of 03 May 2018. The retail portion is oversubscribed.
Subscribe via your broker app using ASBA or UPI. Opens 30 Apr 2018 and closes 03 May 2018. Min investment: ₹102,000 (1 lot = 2,000 shares). UPI mandate: 2018-05-03.
The Indo US Bio-Tech Ltd. IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.
Check allotment on the registrar website. Enter your PAN, application number or DP/Client ID. Allotment date: 09 May 2018. Refunds: on 10 May 2018.
The Indo US Bio-Tech Ltd. IPO listing date is 11 May 2018, Friday. Listed on: BSE SME. Issue price: ₹51. Estimated listing: ₹51. GMP: NIL.
The Indo US Bio-Tech Ltd. IPO closes on 03 May 2018, Thursday. UPI mandate: 2018-05-03. Allotment: 09 May 2018. Listing: 11 May 2018.